Public Release: 

New report one of the most comprehensive studies on health effects of e-cigarettes

Finds that using e-cigarettes may lead youth to start smoking, adults to stop smoking

National Academies of Sciences, Engineering, and Medicine

WASHINGTON - A new congressionally mandated report from the National Academies of Sciences, Engineering, and Medicine takes a comprehensive look at evidence on the human health effects of e-cigarettes. Although the research base is limited given the relatively short time e-cigarettes have been used, the committee that conducted the study identified and examined over 800 peer-reviewed scientific studies, reaching dozens of conclusions about a range of health impacts.

Evidence suggests that while e-cigarettes are not without health risks, they are likely to be far less harmful than conventional cigarettes, the report says. They contain fewer numbers and lower levels of toxic substances than conventional cigarettes, and using e-cigarettes may help adults who smoke conventional cigarettes quit smoking. However, their long-term health effects are not yet clear. Among youth -- who use e-cigarettes at higher rates than adults do -- there is substantial evidence that e-cigarette use increases the risk of transitioning to smoking conventional cigarettes.

E-cigarettes are a diverse group of products containing a heating element that produces an aerosol from a liquid that users can inhale via a mouthpiece, and include a range of devices such as "cig-a-likes," vape tank systems, and vape mods. Millions of Americans use e-cigarettes, and e-cigarette use is generally greatest among young adults and decreases with age. Use varies substantially across demographic groups, including age, gender, race, and ethnicity. For example, among youth and adults, use is typically greater among males than females.

Whether e-cigarettes have an overall positive or negative impact on public health is currently unknown, the report says. More and better research on e-cigarettes' short- and long-term effects on health and on their relationship to conventional smoking is needed to answer that question with clarity.

"E-cigarettes cannot be simply categorized as either beneficial or harmful," said David Eaton, chair of the committee that wrote the report, and dean and vice provost of the Graduate School of the University of Washington, Seattle. "In some circumstances, such as their use by non-smoking adolescents and young adults, their adverse effects clearly warrant concern. In other cases, such as when adult smokers use them to quit smoking, they offer an opportunity to reduce smoking-related illness."

The report offers conclusions about e-cigarette use and a range of health impacts, including the following, and it notes the strength of the evidence for each conclusion.

Exposure to nicotine

  • There is conclusive evidence that exposure to nicotine from e-cigarettes is highly variable and depends on the characteristics of the device and the e-liquid, as well as on how the device is operated.

  • There is substantial evidence that nicotine intake from e-cigarettes among experienced adult e-cigarette users can be comparable to that from conventional cigarettes.

Exposure to toxic substances

  • There is conclusive evidence that in addition to nicotine, most e-cigarettes contain and emit numerous potentially toxic substances.

  • There is substantial evidence that except for nicotine, exposure to potentially toxic substances from e-cigarettes (under typical conditions of use) is significantly lower compared with conventional cigarettes.

Dependence and abuse liability

  • There is substantial evidence that e-cigarette use results in symptoms of dependence on e-cigarettes.

  • There is moderate evidence that risk and severity of dependence is lower for e-cigarettes than for conventional cigarettes.

  • There is moderate evidence that variability in the characteristics of e-cigarette products (nicotine concentration, flavoring, device type, and brand) is an important determinant of the risk and severity of dependence on e-cigarettes.

Harm reduction

  • There is conclusive evidence that completely substituting e-cigarettes for conventional cigarettes reduces users' exposure to many toxicants and carcinogens present in conventional cigarettes.

  • There is substantial evidence that completely switching from regular use of conventional cigarettes to e-cigarettes results in reduced short-term adverse health outcomes in several organ systems.

Use by youth and young adults

  • There is substantial evidence that e-cigarette use by youth and young adults increases their risk of ever using conventional cigarettes.

Secondhand exposure

  • There is conclusive evidence that e-cigarette use increases airborne concentrations of particulate matter and nicotine in indoor environments compared with background levels.

  • There is moderate evidence that second-hand exposure to nicotine and particulates is lower from e-cigarettes compared with conventional cigarettes.

Cancer

  • There is no available evidence whether or not e-cigarette use is associated with intermediate cancer endpoints in humans. (An intermediate cancer endpoint is a precursor to the possible development of cancer; for example, polyps are lesions that are intermediate cancer endpoints for colon cancer.)

  • There is limited evidence from animal studies using intermediate biomarkers of cancer to support the hypothesis that long-term e-cigarette use could increase the risk of cancer.

Respiratory effects

  • There is no available evidence whether or not e-cigarettes cause respiratory diseases in humans.

  • There is moderate evidence for increased cough and wheeze in adolescents who use e-cigarettes, and an increase in asthma exacerbations.

Injuries and poisonings

  • There is conclusive evidence that e-cigarettes can explode and cause burns and projectile injuries. Such risk is significantly increased when batteries are of poor quality, stored improperly, or are being modified by users.

  • There is conclusive evidence that intentional or accidental exposure to e-liquids (from drinking, eye contact, or skin contact) can result in adverse health effects such as seizures, anoxic brain injury, vomiting, and lactic acidosis.

  • There is conclusive evidence that intentionally or accidentally drinking or injecting e-liquids can be fatal.

Reproductive and developmental effects

  • There is no available evidence whether or not e-cigarettes affect pregnancy outcomes.

  • There is insufficient evidence whether or not maternal e-cigarette use affects fetal development.

Until more definite scientific data are available, population modeling can help estimate the balance of potential benefits and harms. Under the assumption that e-cigarette use increases the rate at which adults quit conventional smoking, modeling projects that use of e-cigarettes will generate a net public health benefit, at least in the short run. The harms caused by the higher rate of conventional cigarette smoking among youth who had used e-cigarettes will take decades to appear. For long-range projections, the net public health benefit is substantially less, and under some scenarios the net impact is harmful.

Maximizing the potential health benefits associated with e-cigarettes, the report says, will require determining with more precision whether and under what conditions e-cigarettes help people quit smoking; discouraging e-cigarette use among youth through education and access restrictions; and increasing the devices' safety through data-driven engineering and design.

###

The study was sponsored by the U.S. Food and Drug Administration. The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide independent, objective analysis and advice to the nation to solve complex problems and inform public policy decisions related to science, technology, and medicine. They operate under an 1863 congressional charter to the National Academy of Sciences, signed by President Lincoln. For more information, visit nationalacademies.org. A committee roster follows.

Social Media:

Follow us on Twitter: @theNASEM and @NASEM_health

Follow us on Instagram: @theNASEM

Follow us on Facebook: @NationalAcademies

Follow the conversation using: #eCigHealthEffects

Resources:

Download the report at http://www.nationalacademies.org/eCigHealthEffects

Contacts:

Dana Korsen, Media Relations Officer
Andrew Robinson, Media Relations Assistant
Office of News and Public Information
202-334-2138; e-mail news@nas.edu
Newsroom

Copies of Public Health Consequences of E-Cigarettes are available from the National Academies Press on the Internet at http://www.nap.edu or by calling 202-334-3313 or 1-800-624-6242. Reporters may obtain a copy from the Office of News and Public Information (contacts listed above).

THE NATIONAL ACADEMIES OF SCIENCES, ENGINEERING, AND MEDICINE

Health and Medicine Division Board on Population Health and Public Health Practice

Committee on the Review of the Health Effects of Electronic Nicotine Delivery Systems

David L. Eaton* (chair)
Dean and Vice Provost
Graduate School
Professor of Environmental and Occupational Health Sciences
School of Public Health
University of Washington
Seattle

Anthony Alberg
Professor and Chair
Department of Epidemiology and Biostatistics
Arnold School of Public Health
University of South Carolina
Columbia

Maciej Goniewicz
Associate Professor of Oncology
Department of Health Behavior
Roswell Park Comprehensive Cancer Center
Buffalo, N.Y.

Adam Leventhal
Associate Professor
Department of Preventive Medicine
Division of Health Behavior Research
Keck School of Medicine
University of Southern California
Los Angeles

José E. Manautou
Professor of Pharmacology and Toxicology, and
Interim Chair
Department of Pharmaceutical Sciences
School of Pharmacy
University of Connecticut
Storrs

Sharon McGrath-Morrow
Professor
Department of Pediatrics
School of Medicine
Johns Hopkins University
Baltimore

David Mendez
Associate Professor
Department of Health Management and Policy
School of Public Health
University of Michigan
Ann Arbor

Richard Miech
Research Professor
Survey Research Center
Institute for Social Research
University of Michigan
Ann Arbor

Ana Navas-Acien
Professor of Environmental Health Sciences
Mailman School of Public Health
Columbia University
New York City

Kent E. Pinkerton
Professor of Pediatrics
School of Medicine, and
Professor of Anatomy, Physiology, and Cell Biology
School of Veterinary Medicine
University of California
Davis

Nancy A. Rigotti
Professor of Medicine
Harvard Medical School, and
Director
Tobacco Research and Treatment Center, and
Associate Chief
Division of General Internal Medicine
Massachusetts General Hospital
Boston

David A. Savitz*
Professor of Epidemiology
School of Public Health, and
Professor of Obstetrics and Gynecology and Pediatrics
Warren Alpert Medical School
Brown University
Providence, R.I.

Gideon St.Helen
Assistant Professor of Medicine
Division of Clinical Pharmacology
Department of Medicine
University of California
San Francisco

STAFF

Kathleen R. Stratton
Staff Officer

*Member, National Academy of Medicine

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.